Jean-Jacques Feige Selected Research

Carcinogenesis

1/2019	Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis.
3/2015	A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Jacques Feige Research Topics

Disease

13	Neoplasms (Cancer) 01/2019 - 01/2003
11	Chagas Disease (American Trypanosomiasis) 01/2022 - 12/2002
8	Fibrosis (Cirrhosis) 01/2022 - 12/2002
7	Hypoxia (Hypoxemia) 01/2019 - 11/2004
5	Infections 01/2022 - 10/2005
5	Pre-Eclampsia (Preeclampsia) 01/2016 - 04/2006
5	Hereditary Hemorrhagic Telangiectasia 02/2015 - 03/2007
4	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2016 - 02/2013
4	Hyperplasia 10/2010 - 01/2006
3	Heart Diseases (Heart Disease) 01/2022 - 10/2008
3	Vascular Remodeling 01/2018 - 06/2012
3	Cushing Syndrome 10/2010 - 01/2006
3	Adenoma (Adenomas) 10/2010 - 03/2005
2	Pulmonary Arterial Hypertension 01/2019 - 06/2009
2	Carcinogenesis 01/2019 - 03/2015
2	Inflammation (Inflammations) 01/2019 - 10/2008
2	Pulmonary Hypertension 01/2019 - 01/2019
2	Adrenocortical Carcinoma 01/2018 - 03/2005
2	Parasitemia 01/2012 - 11/2009
2	Acth-Independent Macronodular Adrenal Hyperplasia 10/2010 - 12/2007
2	Vascular Diseases (Vascular Disease) 06/2009 - 11/2007
2	Cardiomyopathies (Cardiomyopathy) 10/2008 - 12/2002
2	Atrophy 11/2004 - 09/2004
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Right Ventricular Hypertrophy 01/2019
1	Sinus Arrhythmia 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Perinatal Death 01/2018
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2018
1	Obesity 01/2018
1	Fetal Weight 01/2016
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 08/2015
1	Placenta Diseases (Placenta Disorder) 01/2014
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2014
1	Pituitary ACTH Hypersecretion 10/2010

Drug/Important Bio-Agent (IBA)

12	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 10/2005
8	CytokinesIBA 01/2022 - 11/2004
8	Messenger RNA (mRNA)IBA 10/2019 - 11/2004
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2004
7	Endocrine-Gland-Derived Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor, Endocrine Gland Derived)IBA 01/2016 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2010
5	Activin Receptors (Activin Receptor)IBA 01/2019 - 11/2007
5	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2010 - 09/2004
4	Growth Differentiation Factor 2IBA 10/2019 - 01/2018
4	LigandsIBA 01/2019 - 03/2007
4	EndoglinIBA 01/2016 - 06/2009
3	Connexin 43 (Connexin43)IBA 01/2019 - 12/2009
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2016 - 04/2006
3	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2010 - 02/2006
3	Hormones (Hormone)IBA 12/2007 - 11/2004
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2018
2	Codon (Codons)IBA 01/2021 - 01/2018
2	4- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA 01/2019 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2018 - 11/2007
2	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2012
2	EnzymesIBA 09/2011 - 03/2005
2	Oxygen (Dioxygen)IBA 09/2011 - 04/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2010 - 02/2006
2	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2010 - 12/2007
2	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 11/2009 - 08/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2006 - 11/2004
2	Thrombospondin 1IBA 04/2004 - 01/2003
1	Monoclonal AntibodiesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Chemokine CX3CL1IBA 01/2019
1	AdrenomedullinIBA 01/2019
1	Bone Morphogenetic Protein ReceptorsIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	ApelinIBA 01/2019
1	Vasoconstrictor AgentsIBA 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	VimentinIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019
1	MonocrotalineIBA 01/2019
1	AntibodiesIBA 01/2019
1	ChemokinesIBA 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2016
1	COB223IBA 03/2015
1	CopperIBA 02/2013
1	Cytostatic AgentsIBA 02/2013
1	Retinaldehyde (Retinal)IBA 06/2012
1	Collagen Type I (Type I Collagen)IBA 01/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	thiamine triphosphorate (TTP)IBA 09/2011
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 09/2011
1	TristetraprolinIBA 09/2011
1	3' Untranslated Regions (3' UTR)IBA 09/2011
1	LuciferasesIBA 09/2011
1	Transcription Factors (Transcription Factor)IBA 09/2011
1	MotilinIBA 10/2010

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2007
1	Induced Abortion (Induced Abortions) 01/2018
1	Oral Administration 01/2012